ID   MO1043
AC   CVCL_Y383
SY   Mo1043
DR   Wikidata; Q54906283
RX   PubMed=8412300;
RX   PubMed=19358282;
CC   Misspelling: M01043; Note=Occasionally.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 8
//
RX   PubMed=8412300; DOI=10.1016/0145-2126(93)90154-D;
RA   Kawata A., Han T., Dadey B., Weier H.-U.G., Okazaki M., Yokota S.,
RA   Fukiage T., Xiao H., Block A.M.W., Barcos M.P., Henderson E.,
RA   Yoshida M., Seon B.K.;
RT   "Establishment and characterization of the tumors of chronic
RT   lymphocytic leukemia cell line in nude and SCID mice.";
RL   Leuk. Res. 17:883-894(1993).
//
RX   PubMed=19358282; DOI=10.1002/ijc.24351;
RA   Inagaki A., Ishida T., Yano H., Ishii T., Kusumoto S., Ito A., Ri M.,
RA   Mori F., Ding J.-M., Komatsu H., Iida S., Ueda R.;
RT   "Expression of the ULBP ligands for NKG2D by B-NHL cells plays an
RT   important role in determining their susceptibility to
RT   rituximab-induced ADCC.";
RL   Int. J. Cancer 125:212-221(2009).
//